Alimera Sciences Inc ALIM:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 04/26/24 EDT
3.49quote price arrow up+0.18 (+5.44%)
Volume
16,998
52 week range
1.56 - 4.38
Loading...
  • Open3.28
  • Day High3.50
  • Day Low3.28
  • Prev Close3.31
  • 52 Week High4.38
  • 52 Week High Date01/02/24
  • 52 Week Low1.56
  • 52 Week Low Date05/12/23

Key Stats

  • Market Cap182.717M
  • Shares Out52.35M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta1.22
  • YTD % Change-19.21

KEY STATS

  • Open3.28
  • Day High3.50
  • Day Low3.28
  • Prev Close3.31
  • 52 Week High4.38
  • 52 Week High Date01/02/24
  • 52 Week Low1.56
  • 52 Week Low Date05/12/23
  • Market Cap182.717M
  • Shares Out52.35M
  • 10 Day Average Volume0.03M
  • Dividend-
  • Dividend Yield-
  • Beta1.22
  • YTD % Change-19.21

RATIOS/PROFITABILITY

  • EPS (TTM)-2.16
  • P/E (TTM)-1.61
  • Fwd P/E (NTM)-61.23
  • EBITDA (TTM)6.815M
  • ROE (TTM)-697.34%
  • Revenue (TTM)80.754M
  • Gross Margin (TTM)86.58%
  • Net Margin (TTM)-24.93%
  • Debt To Equity (MRQ)140.10%

EVENTS

  • Earnings Date05/13/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Alimera Sciences Inc

 

Profile

MORE
Alimera Sciences, Inc. is a global pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic retinal pharmaceuticals. It is engaged in developing and commercializing ILUVIEN for the treatment of diabetic macular edema (DME), a cause of blindness, and outside the United States for non-infectious uveitis affecting the posterior segment of the eye (NIU-PS). ILUVIEN is a sustained-release intravitreal implant that enables patients...
C. Daniel Myers
Non-Executive Chairman of the Board
Richard Eiswirth Jr.
President, Chief Executive Officer, Director
Jason Werner
Chief Operating Officer, Director
Elliot Maltz CPA
Chief Financial Officer
Address
STE 290, 6120 WINDWARD PARKWAY
Alpharetta, GA
30005
United States

Top Peers

SYMBOLLASTCHG%CHG
OPTN
OptiNose Inc
0.8604-0.0446-4.9282%
CDXC
Chromadex Corp
3.44+0.05+1.47%
MEIP
MEI Pharma Inc
3.05-0.05-1.61%
SCPH
scPharmaceuticals Inc
4.49+0.14+3.22%
MDWD
Mediwound Ltd
18.24+0.58+3.28%